cvictorg
New Member
http://www.nytimes.com/2012/10/12/s...l=1&adxnnlx=1349989832-Zm85FFN1FmAwXITATT1S2Q
http://cyclinginvestigation.usada.org/
"As part of its investigation, Usada asked Christopher J. Gore, the head of physiology at the Australian Institute of Sport, to analyze test results from 38 blood samples taken from Armstrong between February 2009 and the end of last April. Those taken during the 2009 and 2010 Tours de France, the report said, show blood values in which the likelihood “of occurring naturally was less than one in a million” and other indications of blood doping."
"The most basic technique outlined in the report, based on affidavits from some of Armstrong’s former teammates, was simply running away or hiding.
“The most conventional way that the U.S. Postal riders beat what little out-of-competition testing there was, was to simply use their wits to avoid the testers,” the report concluded.
To facilitate out-of-competition testing, professional cyclists are required to inform their national antidoping agencies of their locations at all times. Any rider who receives three warnings in an 18-month period for either providing their whereabouts inaccurately or not filing the information at all can be punished as if they had a positive drug test.
Noting that “the adequacy of unannounced, no-notice testing taking place in the sport of cycling remains a concern,” Usada outlined several methods used by Armstrong and his teammates to circumvent the system.
The simplest was pretending not to be home when the testers arrived. As long as they were in the city they had reported as their locations, the riders found they would not receive a warning for not answering the door.
The agency compared the whereabouts information it received from Armstrong over the years with messages between Armstrong and Michele Ferrari, a sports medicine doctor who is also a target of the doping investigation. There were revealing discrepancies, the report said.
Travel plans that Armstrong conveyed months in advance to Ferrari through training and racing diaries were submitted to Usada weeks later, sometimes the day he made the trip. While those last-minute changes did not break any rules, they frustrated the agency’s testing plans. The doping agency also found that Armstrong often stayed at a remote hotel in Spain where he “was virtually certain not to be tested.”
According to the report, Armstrong abruptly dropped out of one race after his teammate George Hincapie warned him through a text message that drug testers were at the team’s hotel. Armstrong had, Hincapie said in an affidavit, just taken a solution containing olive oil and testosterone."
"Riders on Armstrong’s team, the agency said, also kept a constant lookout for testers and relayed information about them to one another. Team officials often seemed to know when a supposedly unannounced drug test would occur.
When the testers could not be avoided, Armstrong and his teammates turned to drug masking. The report indicated that during the 1998 world championships, testers were diverted to other riders on the United States team while one of Armstrong’s doctors “smuggled a bag of saline under his raincoat, getting it past the tester and administering saline to Armstrong before Armstrong was required to provide a blood sample.”
The saline infusion restored Armstrong’s blood values to a level that would not attract attention.
The report also showed how Armstrong, often in conjunction with Ferrari and the team director Johan Bruyneel, was careful to use techniques and drugs that were untraceable through tests.
During his first Tour de France victory, in 1999, Armstrong’s drug of choice was the blood-boosting hormone known as EPO, according to the sworn affidavits. At that time, there was no test for EPO, which is a cloned form of human hormone rather than a synthetic product.
But when rumors began circulating about the arrival of a test for EPO, Armstrong and some of his teammates switched to withdrawing and then reinfusing their own blood. Again, it was a technique initially without a test.
Ferrari discovered that when regular, if small, doses of EPO were injected directly into veins rather than under the skin, Armstrong and others could continue using the hormone without fear of a positive test result, the report found.
Armstrong and his teammates also learned from Ferrari that the test for testosterone was not highly sensitive and caught only those who carelessly used the drug at times of the day when testing was likely or who consumed large amounts of it. A test for human growth hormone, another banned substance with a following among members of the Postal Service team, was introduced only this year at the London Olympic.
According to the report, the drugs used by Armstrong and his teammates were generally supplied by Jose Marti, often at clandestine meetings. Better known as Pepe, Marti ostensibly worked as a trainer for Armstrong’s United States Postal Service and Discovery Channel teams. But several riders told Usada that his training largely involved relaying information from Ferrari, who was apparently careful only to give advice rather than administer or supply drugs. Marti, who also helped with the team’s blood transfusions, sometimes sold drugs to riders on other teams, according to the report.
Contrary to Armstrong’s repeated claim that he never tested positive, it was widely reported at the time that he tested positive for a corticosteroid during the 1999 Tour de France. But he was not sanctioned because the team produced a prescription from one of its doctors indicating that Armstrong had received it in a cream used to treat a saddle sore.
Usada, however, contends in the report that the prescription and its explanation were both shams. In his affidavit to Usada, Tyler Hamilton, the disgraced former Olympic champion and Armstrong teammate, said that the positive test prompted “a great deal of swearing from Lance and Johan.” A backdated prescription, a former team employee told Usada, was created to resolve the problem.
As part of its investigation, Usada said that it recently obtained additional data from French officials who had retested Armstrong’s samples from the 1999 Tour de France. For procedural reasons, those samples cannot be used to sanction Armstrong. But the Usada report indicated that advances in EPO testing since then conclusively show that he used the hormone. The report said the retesting produced “resoundingly positive values” from six samples."
http://cyclinginvestigation.usada.org/
"As part of its investigation, Usada asked Christopher J. Gore, the head of physiology at the Australian Institute of Sport, to analyze test results from 38 blood samples taken from Armstrong between February 2009 and the end of last April. Those taken during the 2009 and 2010 Tours de France, the report said, show blood values in which the likelihood “of occurring naturally was less than one in a million” and other indications of blood doping."
"The most basic technique outlined in the report, based on affidavits from some of Armstrong’s former teammates, was simply running away or hiding.
“The most conventional way that the U.S. Postal riders beat what little out-of-competition testing there was, was to simply use their wits to avoid the testers,” the report concluded.
To facilitate out-of-competition testing, professional cyclists are required to inform their national antidoping agencies of their locations at all times. Any rider who receives three warnings in an 18-month period for either providing their whereabouts inaccurately or not filing the information at all can be punished as if they had a positive drug test.
Noting that “the adequacy of unannounced, no-notice testing taking place in the sport of cycling remains a concern,” Usada outlined several methods used by Armstrong and his teammates to circumvent the system.
The simplest was pretending not to be home when the testers arrived. As long as they were in the city they had reported as their locations, the riders found they would not receive a warning for not answering the door.
The agency compared the whereabouts information it received from Armstrong over the years with messages between Armstrong and Michele Ferrari, a sports medicine doctor who is also a target of the doping investigation. There were revealing discrepancies, the report said.
Travel plans that Armstrong conveyed months in advance to Ferrari through training and racing diaries were submitted to Usada weeks later, sometimes the day he made the trip. While those last-minute changes did not break any rules, they frustrated the agency’s testing plans. The doping agency also found that Armstrong often stayed at a remote hotel in Spain where he “was virtually certain not to be tested.”
According to the report, Armstrong abruptly dropped out of one race after his teammate George Hincapie warned him through a text message that drug testers were at the team’s hotel. Armstrong had, Hincapie said in an affidavit, just taken a solution containing olive oil and testosterone."
"Riders on Armstrong’s team, the agency said, also kept a constant lookout for testers and relayed information about them to one another. Team officials often seemed to know when a supposedly unannounced drug test would occur.
When the testers could not be avoided, Armstrong and his teammates turned to drug masking. The report indicated that during the 1998 world championships, testers were diverted to other riders on the United States team while one of Armstrong’s doctors “smuggled a bag of saline under his raincoat, getting it past the tester and administering saline to Armstrong before Armstrong was required to provide a blood sample.”
The saline infusion restored Armstrong’s blood values to a level that would not attract attention.
The report also showed how Armstrong, often in conjunction with Ferrari and the team director Johan Bruyneel, was careful to use techniques and drugs that were untraceable through tests.
During his first Tour de France victory, in 1999, Armstrong’s drug of choice was the blood-boosting hormone known as EPO, according to the sworn affidavits. At that time, there was no test for EPO, which is a cloned form of human hormone rather than a synthetic product.
But when rumors began circulating about the arrival of a test for EPO, Armstrong and some of his teammates switched to withdrawing and then reinfusing their own blood. Again, it was a technique initially without a test.
Ferrari discovered that when regular, if small, doses of EPO were injected directly into veins rather than under the skin, Armstrong and others could continue using the hormone without fear of a positive test result, the report found.
Armstrong and his teammates also learned from Ferrari that the test for testosterone was not highly sensitive and caught only those who carelessly used the drug at times of the day when testing was likely or who consumed large amounts of it. A test for human growth hormone, another banned substance with a following among members of the Postal Service team, was introduced only this year at the London Olympic.
According to the report, the drugs used by Armstrong and his teammates were generally supplied by Jose Marti, often at clandestine meetings. Better known as Pepe, Marti ostensibly worked as a trainer for Armstrong’s United States Postal Service and Discovery Channel teams. But several riders told Usada that his training largely involved relaying information from Ferrari, who was apparently careful only to give advice rather than administer or supply drugs. Marti, who also helped with the team’s blood transfusions, sometimes sold drugs to riders on other teams, according to the report.
Contrary to Armstrong’s repeated claim that he never tested positive, it was widely reported at the time that he tested positive for a corticosteroid during the 1999 Tour de France. But he was not sanctioned because the team produced a prescription from one of its doctors indicating that Armstrong had received it in a cream used to treat a saddle sore.
Usada, however, contends in the report that the prescription and its explanation were both shams. In his affidavit to Usada, Tyler Hamilton, the disgraced former Olympic champion and Armstrong teammate, said that the positive test prompted “a great deal of swearing from Lance and Johan.” A backdated prescription, a former team employee told Usada, was created to resolve the problem.
As part of its investigation, Usada said that it recently obtained additional data from French officials who had retested Armstrong’s samples from the 1999 Tour de France. For procedural reasons, those samples cannot be used to sanction Armstrong. But the Usada report indicated that advances in EPO testing since then conclusively show that he used the hormone. The report said the retesting produced “resoundingly positive values” from six samples."
